tradingkey.logo
搜尋

BNB Plus Ord Shs

BNBX
添加自選
0.163USD
0.0000.00%
收盤 07-13 16:00(美東)
836.63K總市值
0.00本益比TTM

關於 BNB Plus Ord Shs 公司

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.

BNB Plus Ord Shs 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

BNB Plus Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
+0.00%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.51K
-0.01%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President, Chief Executive Officer
President, Chief Executive Officer
12.62K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President, Chief Executive Officer
President, Chief Executive Officer
12.62K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President, Chief Executive Officer
President, Chief Executive Officer
12.62K
--
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
10.21K
-0.01%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
+0.00%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.51K
-0.01%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%

常見問題

BNB Plus Ord Shs的前五大股東是誰?

BNB Plus Ord Shs的前五大股東如下:Dr. Yacov A. Shamash, Ph.D.

哪個業務部門對BNB Plus Ord Shs的收入貢獻最大?

在2026Q4,Product and authentication services - Large scale DNA production業務部門對BNB Plus Ord Shs的收入貢獻最大,創收423.01K,占總收入的74.82% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有